Our Journey
Key Milestones
1998
- Indegene founded
2000
- Introduced medical education services to Indian pharmaceutical companies
- Launched Indegene Mobile Health System (IMHS) for medical doctors to easily access licensed medical content via PalmPilots
2001
- Recognized by Lancet as the most credible source of specialized medical information in India
- Selected by WHO as their partner to implement a nationwide healthcare information project
2003
- Made a successful entry into sales training through the launch of e-learning platform in diabetes across S.E. Asia
2004
- Incorporated 100% subsidiaries in the United States and Singapore
2005
- Nadathur Investments invested in Indegene
- Set up operations in the United States
- Acquired Medsn, a pharma sales training company in the United States
2006
- Ramped up operations in Southeast Asia
- Acquired MedCases, a medical e-learning solutions company in the United States
2007
- Kicked off operations in Europe
- Received ISO 9001 and ISO 27001 certifications
- Launched Medical Affairs service
2010
- Built China Operation Center at Shanghai and Dalian
2011
- Launched Analytics services
2012
- Introduced Regulatory Affairs and Safety services
- Acquired Aptilon, a customer engagement technology company
2013
- Acquired Total Therapeutic Management (TTM), a healthcare quality improvement and clinician engagement company
2015
- Acquired SmartCare, a population health analytics platform
2016
- Acquired Skura Technologies to expand omnichannel and commercial solutions
- Acquired Encima to strengthen omnichannel analytics capabilities
- Introduced next-generation, fully integrated product commercialization solutions
- Acquired Wincere to strengthen footprint in R&D and Medical offerings for life sciences
2017
- Introduced Clinical services
2019
- Acquired DT Associates, a digital transformation and customer experience consulting firm in the UK
- Launched Indegene Digital Summit, a flagship thought leadership event
2020
- Set up operations in Japan
2021
- The Carlyle Group and Brighton Park Capital invested $200 million in Indegene
- Indegene refreshed its brand to align with its purpose - To enable healthcare organizations be future-ready
- Strengthened pricing, reimbursement and market access capabilities with MME acquisition
2022
- Acquired CultHealth, a full-service healthcare marketing agency to elevate brand experience
2023
- Opened strategic center in Germany
2024
- Set up a new global delivery center in Hyderabad
- Acquired Trilogy Writing & Consulting GmbH, a medical writing consultancy
- Indegene listed on NSE and BSE
2025
- Acquired MJL Life Sciences to expand healthcare communications in the UK
- Launched a new entity in Spain
- Acquired US-based BioPharm to expand AI-driven commercialization and AdTech capabilities
- Strengthened Consulting Practice to accelerate life sciences transformation
- Acquired Warn & Co.
- Opened new global delivery centers in London, Pune, and Mumbai
2026
- Acquired CAKE Health
- Opened a new global delivery center in Noida